Lifevantage (NASDAQ:LFVN) Downgraded by Wall Street Zen to “Hold”

Wall Street Zen downgraded shares of Lifevantage (NASDAQ:LFVN) from a buy rating to a hold rating in a report published on Friday.

Separately, Weiss Ratings restated a “hold (c+)” rating on shares of Lifevantage in a research report on Saturday, September 27th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Lifevantage presently has an average rating of “Moderate Buy” and a consensus target price of $30.50.

Lifevantage Stock Down 0.9%

NASDAQ LFVN opened at $9.48 on Friday. Lifevantage has a twelve month low of $9.44 and a twelve month high of $27.38. The firm has a market capitalization of $120.30 million, a PE ratio of 12.81 and a beta of 0.26. The stock’s 50 day moving average is $12.13 and its 200 day moving average is $12.83.

Lifevantage (NASDAQ:LFVN) last released its quarterly earnings results on Thursday, September 4th. The company reported $0.17 earnings per share for the quarter, meeting the consensus estimate of $0.17. Lifevantage had a return on equity of 33.75% and a net margin of 4.29%.The company had revenue of $55.11 million for the quarter, compared to analyst estimates of $57.93 million. During the same period in the previous year, the company posted $0.14 earnings per share. Lifevantage has set its FY 2026 guidance at 1.000-1.15 EPS.

Lifevantage Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 16th. Shareholders of record on Monday, September 8th were issued a $0.045 dividend. This represents a $0.18 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend was Monday, September 8th. Lifevantage’s payout ratio is 24.32%.

Insider Buying and Selling

In other Lifevantage news, Director Michael A. Beindorff sold 4,125 shares of the business’s stock in a transaction on Tuesday, September 9th. The stock was sold at an average price of $11.44, for a total value of $47,190.00. Following the sale, the director directly owned 22,858 shares of the company’s stock, valued at approximately $261,495.52. The trade was a 15.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 21.95% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Farther Finance Advisors LLC bought a new position in shares of Lifevantage during the second quarter valued at $25,000. Police & Firemen s Retirement System of New Jersey bought a new position in shares of Lifevantage during the second quarter valued at $31,000. JPMorgan Chase & Co. lifted its holdings in shares of Lifevantage by 870.2% during the second quarter. JPMorgan Chase & Co. now owns 5,016 shares of the company’s stock valued at $66,000 after purchasing an additional 4,499 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of Lifevantage during the second quarter valued at $76,000. Finally, BNP Paribas Financial Markets lifted its holdings in shares of Lifevantage by 2,555.8% during the second quarter. BNP Paribas Financial Markets now owns 6,135 shares of the company’s stock valued at $80,000 after purchasing an additional 5,904 shares in the last quarter. 35.32% of the stock is owned by institutional investors.

About Lifevantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.